rivaroxaban oral suspension — Medica
Atrial fibrillation (or atrial flutter)
Initial criteria
- Patient is age ≥ 18 years
- If rivaroxaban oral suspension is being requested, patient is unable to have Xarelto tablets appropriately administered
Approval duration
1 year